Your browser doesn't support javascript.
loading
Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes.
Herold, Kevan C; Bucktrout, Samantha L; Wang, Xiao; Bode, Bruce W; Gitelman, Stephen E; Gottlieb, Peter A; Hughes, Jing; Joh, Tenshang; McGill, Janet B; Pettus, Jeremy H; Potluri, Shobha; Schatz, Desmond; Shannon, Megan; Udata, Chandrasekhar; Wong, Gilbert; Levisetti, Matteo; Ganguly, Bishu J; Garzone, Pamela D.
Afiliação
  • Herold KC; Department of Immunobiology and.
  • Bucktrout SL; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Wang X; Rinat, Pfizer Inc., South San Francisco, California, USA.
  • Bode BW; Rinat, Pfizer Inc., South San Francisco, California, USA.
  • Gitelman SE; Atlanta Diabetes Associates Research, Atlanta, Georgia, USA.
  • Gottlieb PA; Department of Pediatrics and.
  • Hughes J; Diabetes Center, UCSF, San Francisco, California, USA.
  • Joh T; Department of Pediatrics.
  • McGill JB; Department of Medicine, and.
  • Pettus JH; Barbara Davis Diabetes Center, University of Colorado School of Medicine Anschutz Medical Campus, Anschutz, Colorado, USA.
  • Potluri S; Division of Endocrinology, Metabolism and Lipid Research, John T. Milliken Department of Internal Medicine, Washington University School of Medicine in Saint Louis, Saint Louis, Missouri, USA.
  • Schatz D; Worldwide R&D, Pfizer Inc., San Diego, California, USA.
  • Shannon M; Division of Endocrinology, Metabolism and Lipid Research, John T. Milliken Department of Internal Medicine, Washington University School of Medicine in Saint Louis, Saint Louis, Missouri, USA.
  • Udata C; Department of Medicine, VA San Diego Healthcare System, San Diego, California, USA.
  • Wong G; Rinat, Pfizer Inc., South San Francisco, California, USA.
  • Levisetti M; Department of Pediatrics, College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Ganguly BJ; Worldwide R&D, Pfizer Inc., San Diego, California, USA.
  • Garzone PD; Worldwide R&D, Pfizer Inc., San Diego, California, USA.
JCI Insight ; 4(24)2019 12 19.
Article em En | MEDLINE | ID: mdl-31852846

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Subunidade alfa de Receptor de Interleucina-7 / Anticorpos Monoclonais Humanizados / Memória Imunológica Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Subunidade alfa de Receptor de Interleucina-7 / Anticorpos Monoclonais Humanizados / Memória Imunológica Idioma: En Ano de publicação: 2019 Tipo de documento: Article